» Articles » PMID: 35509644

[Vaccination Against SARS-CoV-2 and Its Relationship with Illness and Death from COVID-19 in ArgentinaVacinação Contra SARS-CoV-2 E Sua Relação Com Doença E Morte Por COVID-19 Na Argentina]

Abstract

Objective: To determine the effectiveness of vaccination against SARS-CoV-2 in preventing illness and death from COVID-19 in Córdoba, Argentina, during the period from January through June 2021.

Methods: A retrospective cohort study was conducted among 1,139,458 residents of the province of Córdoba. Multiple logistic regression models were developed to describe the relationship between vaccination and the presence of SARS-CoV-2 or death from COVID-19, while taking account of comorbidities and chronic disease risk factors and adjusting for sex and age.

Results: Among the general population, having received one or two doses of vaccine reduced the risk of illness by 98.8% and 99.3%, respectively, and the risk of dying by 83% and 96.5%, respectively. Among those who developed COVID-19, the probability of dying was reduced by 57% and 80%, respectively. Regarding probability of death, risk increased with age, with being male, and with obesity, arterial hypertension, and diabetes mellitus.

Conclusion: Vaccination is effective and protects against the risk of getting COVID-19, developing severe disease, or dying. Having obesity, arterial hypertension, or diabetes mellitus, in descending order, increases the risk of death.

Citing Articles

COVID-19 mortality: educational inequalities and socio-spatial context in two provinces of Argentina.

Leveau C, Velazquez G Rev Peru Med Exp Salud Publica. 2024; 41(2):171-177.

PMID: 39166640 PMC: 11300695. DOI: 10.17843/rpmesp.2024.412.13201.


Non-traditional data sources in obesity research: a systematic review of their use in the study of obesogenic environments.

Wirtz Baker J, Pou S, Niclis C, Haluszka E, Aballay L Int J Obes (Lond). 2023; 47(8):686-696.

PMID: 37393408 DOI: 10.1038/s41366-023-01331-3.

References
1.
Rubio Herrera M, Breton Lesmes I . [Obesity in the COVID era: A global health challenge]. Endocrinol Diabetes Nutr. 2024; 68(2):123-129. PMC: 7577699. DOI: 10.1016/j.endinu.2020.10.001. View

2.
Aballay L, Eynard A, Diaz M, Navarro A, Munoz S . Overweight and obesity: a review of their relationship to metabolic syndrome, cardiovascular disease, and cancer in South America. Nutr Rev. 2013; 71(3):168-79. DOI: 10.1111/j.1753-4887.2012.00533.x. View

3.
Pranata R, Lim M, Huang I, Yonas E, Henrina J, Vania R . Visceral adiposity, subcutaneous adiposity, and severe coronavirus disease-2019 (COVID-19): Systematic review and meta-analysis. Clin Nutr ESPEN. 2021; 43:163-168. PMC: 8032475. DOI: 10.1016/j.clnesp.2021.04.001. View

4.
Abu-Raddad L, Chemaitelly H, Butt A . Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants. N Engl J Med. 2021; 385(2):187-189. PMC: 8117967. DOI: 10.1056/NEJMc2104974. View

5.
Aguilera C, Labbe T, Busquets J, Venegas P, Neira C, Valenzuela A . [Obesity: risk factor or primary disease?]. Rev Med Chil. 2019; 147(4):470-474. DOI: 10.4067/S0034-98872019000400470. View